Ernexa Therapeutics
ERNA----
Ernexa Therapeutics (ERNA)
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Ernexa Therapeutics Analyst Rating
View MoreForecast & Rating
May 27, 2026Price forecast
$30.00574.16%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 16 at 09:52 AM
3 Most Active Penny Stocks to Watch Today, 7/16/2026
- US Stock Market Update · Jul 15 at 12:52 PM
Ernexa Therapeutics climbs 7% during regular trading to $6.47
- benzinga_article · Jul 15 at 08:43 AM
Dow Gains Over 150 Points; Morgan Stanley Profit Tops Views
- US Stock Market Update · Jul 15 at 08:41 AM
Ernexa Therapeutics surges 40% intraday after 88% premarket jump
- benzinga_article · Jul 15 at 07:05 AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- StockTitan · Jul 14 at 10:50 PM
Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry | ERNA Stock News
